IP Library Granted Patent US 9,434,926
Granted Patent B1
US 9,434,926 · App. 14/627,671 · Granted Sep 6, 2016

Graphene hydrogel and methods of using the same

Inventors: Subhra Mohapatra (Tampa, FL); Chunyan Wang (Tampa, FL)
Assignee: University of South Florida
C12N5/0663A61K9/06A61K35/28A61K47/02A61K47/14A61K47/36C12N2501/00C12N2533/30C12N2533/72
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,434,926
App. No.
14/627,671
Granted
Sep 6, 2016
Kind
B1
Abstract

Provided herein are hydrogel compositions containing graphene, chitosan, a polyethylene (glycol) diacrylate (PEGDA). The hydrogel can optionally contain an N-isopropylacrylamide (NIPAM) (TPCG hydrogel). Also provided are methods for differentiating a cell on the hydrogels described herein. Further provided herein are methods for delivering a compound via the hydrogels described herein.

Claims (25)

1. A method comprising:

contacting a cell with a hydrogel for a period of time, where the hydrogel comprises:

at least two acrylated chitosan-graphene monomers, where each chitosan-graphene monomer comprises:

carboxylic acid functionalized graphene, where the chitosan component of the chitosan-graphene monomer is covalently bonded to the carboxylic acid functionalized graphene component of the chitosan-graphene monomer; and

polyethylene (glycol) diacrylate (PEGDA), where the (PEGDA) covalently crosslinks the at least two acrylated chitosan-graphene monomers.

2. The method of claim 1 , further comprising the step of culturing the cell and the hydrogel in cell culture media.

3. The method of claim 2 , where the cell culture media is a differentiation cell culture media.

4. The method of claim 3 , wherein the differentiation cell culture media is an adipogenic cell culture media, osteogenic cell culture media, chondrogenic cell culture media, or combination thereof.

5. The method of claim 3 , wherein the cell and hydrogel are cultured in the differentiation cell culture media for about 7 days.

6. The method of claim 1 , wherein the cell is a stem cell.

7. The method of claim 6 , wherein the stem cell is selected from the group consisting of: a pluripotent stem cell, a totipotent stem cell, a multipotent stem cell, an adult stem cell, and an induced pluripotent stem cell.

8. The method of claim 1 , wherein the cell is a bone-marrow mesenchymal stem cell.

9. The method of claim 1 , where the period of time ranges from about 1 hour to about 14 days.

10. The method of claim 1 , wherein the cell proliferates to form a population of cells after the period of time.

11. The method of claim 10 , wherein the population of cells is harvested by separating the population of cells from the hydrogel to form harvested cells.

12. The method of claim 11 , wherein the harvested cells are delivered to a subject in need thereof.

13. The method of claim 12 , wherein the cell is autologous, allogenic, xenogeneic, or syngeneic.

14. The method claim 1 , wherein after the period of time the cell differentiates to form a differentiated population of cells.

15. The method of claim 14 , wherein the differentiated population of cells contains at least one cell selected from the group consisting of: a chondrocyte, an adipocyte, and an osteocyte.

16. The method of claim 14 , wherein the differentiated population of cells is harvested by separating the differentiated population of cells from the hydrogel.

17. The method of claim 16 , wherein the cell is autologous, allogenic, xenogeneic, or syngeneic.

18. The method of claim 14 , wherein the graphene enhances differentiation of the cell.

19. The method of claim 10 , further comprising the step of delivering the hydrogel and the population of cells to a subject in need thereof.

20. The method of claim 14 , further comprising the step of delivering the hydrogel and the differentiated population of cells to a subject in need thereof.

21. The method of claim 1 , wherein the hydrogel further comprises N-Isopropylacrylamide (NIPAM), where the NIPAM is crosslinked at least one of the acrylated chitosan-graphenemonomers.

Assignments (1)
CONFIRMATORY LICENSE Recorded May 28, 2015
From: UNIVERSITY OF SOUTH FLORIDA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035771/0429 →
Continuity (4)
Continuation In Part 13775560 · Feb 25, 2013
Provisional Application 61602352 · Feb 23, 2012
Provisional Application 61602378 · Feb 23, 2012
Provisional Application 61942556 · Feb 20, 2014